UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 18, 2007
PINNACLE FINANCIAL PARTNERS, INC.
(Exact name of registrant as specified in charter)
| |
|
|
|
|
| Tennessee
|
|
000-31225
|
|
62-1812853 |
| |
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.) |
| |
|
|
211 Commerce Street, Suite 300, Nashville, Tennessee
|
|
37201 |
| |
(Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (615) 744-3700
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) On November 27, 2007, the Nominating and Corporate Governance Committee of the Board of
Directors of Pinnacle Financial Partners, Inc. recommended, and on December 18, 2007, the Board of
Directors elected, effective as of January 1, 2008, Dr. Wayne Joseph Riley to the Company’s Board
of Directors. Dr. Riley will serve as a Class II director.
Dr. Riley has been appointed to serve on the Audit Committee and Nominating and Corporate
Governance Committee of the Company’s Board of Directors effective as of March 1, 2008.
Dr. Riley is not a party to any arrangement or understanding with any person pursuant to which
he was selected as a member of the Board of Directors nor is he a party to any transaction, or
series of transactions, required to be disclosed pursuant to Item 404(a) of Regulation S-K.